Skip to main content

GOLDMAN SACHS GROUP INC

Position in NBIX — Neurocrine Biosciences Inc

CIK 886982 NEW YORK, NY

Position in NBIX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$106,499,075
+$60,498,236 QoQ
Shares Held
631,892
+81.0% QoQ
Ownership
0.622%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#26
of 772 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Derivatives in NBIX

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$2,308,998
PutShares
13,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

GOLDMAN SACHS GROUP INC holds $1,964,785,401 across 53 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (5.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 NBIX
Neurocrine Biosciences Inc
This page
631,892 $106,499,075

All Filings in NBIX

Export CSV
41 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $106,499,075 631,892
2026-06-30 $2,308,998 13,700
2026-03-31 $46,000,839 349,179
2026-03-31 $1,804,838 13,700
2025-12-31 $51,701,997 364,535
2025-12-31 $354,575 2,500
2025-09-30 $350,950 2,500
2025-09-30 $85,577,471 609,613
2025-06-30 $402,208 3,200
2025-06-30 $1,420,297 11,300
2025-06-30 $86,206,370 685,865
2025-03-31 $81,560,531 737,437
2024-12-31 $134,288,563 983,799
2024-09-30 $117,196,481 1,017,154
2024-06-30 $155,923,526 1,132,589
2024-03-31 $106,988,266 775,727
2023-12-31 $91,129,431 691,632
2023-09-30 $88,532,437 786,955
2023-06-30 $77,763,269 824,637
2023-03-31 $98,163,154 969,800
2022-12-31 $158,821,995 1,329,722
2022-09-30 $127,642,115 1,201,790
2022-06-30 $122,320,145 1,254,823
2022-03-31 $140,292,374 1,496,452
2021-12-31 $129,842,942 1,524,515
2021-12-31 $2,555,100 30,000
2021-12-31 $2,555,100 30,000
2021-09-30 $138,445,892 1,443,498
2021-06-30 $13,624,800 140,000
2021-06-30 $138,514,387 1,423,288
2021-03-31 $13,615,000 140,000
2021-03-31 $136,876,846 1,407,474
2020-12-31 $14,875,920 155,200
2020-12-31 $116,722,774 1,217,765
2020-09-30 $85,502,682 889,171
2020-09-30 $6,279,248 65,300
2020-06-30 $6,112,200 50,100
2020-06-30 $115,249,618 944,669
2020-03-31 $2,830,185 32,700
2020-03-31 $5,201,655 60,100
2020-03-31 $78,075,196 902,082